Deccan Health Care Ltd vs Suven Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Deccan Health Care Ltd is ₹ 11.93 as of 23 Oct 15:30 . The P/E Ratio of Deccan Health Care Ltd changed from 117.6 on March 2021 to 6.8 on March 2026 . This represents a CAGR of -37.82% over 6 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Deccan Health Care Ltd changed from ₹ 46.2 crore on March 2021 to ₹ 16.95 crore on March 2026 . This represents a CAGR of -15.39% over 6 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 years The revenue of Deccan Health Care Ltd for the Jun '26 is ₹ 22.09 crore as compare to the Mar '26 revenue of ₹ 20.98 crore. This represent the growth of 5.29% The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The ebitda of Deccan Health Care Ltd for the Jun '26 is ₹ 0.93 crore as compare to the Mar '26 ebitda of ₹ 0.89 crore. This represent the growth of 4.49% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The net profit of Deccan Health Care Ltd changed from ₹ 0.36 crore to ₹ 0.29 crore over 9 quarters. This represents a CAGR of -9.16% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The Dividend Payout of Deccan Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Deccan Health Care Ltd

Incorporated on August 31, 2017, Deccan Health Care Limited is developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products.
With an operating history of more than two decades, the company is primarily known for premium range of nutraceutical, ayurveda and cosmeceutical products.
The Company has identified over 80 consumer wellness goals and over 250 diseases, disorders, disabilities which can be prevented by meeting RDA of micronutrients and it has innovated and developed cost effective products that are unique and differentiated to combat such diseases. The Company was initially engaged in trading of Pharmaceuticals till 2005.
From 2005 till 2010 the company was engaged in third party manufacturing.
From 2010 onwards, the Company set up its own Manufacturing Facility at Rudrapur, Uttarakhand.

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

FAQs for the comparison of Deccan Health Care Ltd and Suven Life Sciences Ltd

Which company has a larger market capitalization, Deccan Health Care Ltd or Suven Life Sciences Ltd?

Market cap of Deccan Health Care Ltd is 29 Cr while Market cap of Suven Life Sciences Ltd is 7,397 Cr

What are the key factors driving the stock performance of Deccan Health Care Ltd and Suven Life Sciences Ltd?

The stock performance of Deccan Health Care Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deccan Health Care Ltd and Suven Life Sciences Ltd?

As of October 25, 2026, the Deccan Health Care Ltd stock price is INR ₹11.93. On the other hand, Suven Life Sciences Ltd stock price is INR ₹261.8.

How do dividend payouts of Deccan Health Care Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of Deccan Health Care Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.